KalVista Pharmaceuticals (KALV) Q4 2024 Earnings
KALV·Reported December 5, 2024·Before market open
Diluted EPS came in at $-0.91.
Diluted EPS
$-0.91met estimate
Consensus: $-0.91
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about KalVista Pharmaceuticals's Q4 2024 earnings report.
KalVista Pharmaceuticals (KALV) reported Q4 2024 earnings on December 5, 2024 before market open.
KalVista Pharmaceuticals reported diluted EPS of $-0.91 for Q4 2024.
EPS beat the consensus estimate of $-0.91 by $0.00.
You can read the 10-Q periodic report (0000950170-24-133673) directly on SEC EDGAR. The filing index links above go to sec.gov.